Home > Quotes > SNY

Sanofi American Depositary Shares (Each repstg one-half of one ordinary share) Quote & Summary Data

Get SNY Alerts
*Delayed - data as of May 2, 2016  -  Find a broker to begin trading SNY now
Exchange: NYSE
Industry: Health Care
Community Rating:
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Sanofi American Depositary Shares (Each repstg one-half of one ordinary share) Intraday Chart

News for SNY

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 41.70 $ 54.98
Low $ 41.035 $ 37.63

The current last sale of $41.46 is 10.18% Higher thanthe 52 week low.

P/E Ratio

ETFs with SNY as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
5.05% VanEck Vectors Pharmaceutical ETF (PPH) -7.17 (-10.96%)
3.23% BLDRS Europe 100 ADR Index Fund (ADRU) -1.54 (-7.12%)
2.63% BLDRS Developed Markets 100 ADR Index Fund (ADRD) -1.42 (-6.56%)
1.29% PowerShares Intl Dividend Achievers (PID) +0.12 (0.83%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Sanofi is a leading global healthcare company, focused on patient needs and engaged in the research, development, manufacture and marketing of therapeutic solutions. In 2015, our net sales were €34,542 million. This figure excludes net sales of our Animal Health activity. Our aggregate net sales (including Animal Health, see definition at "Item 5 - Results of Operations - Year Ended December 31, 2015 Compared with Year Ended December 31, 2014" below) were €37,057 million. We are the fifth largest pharmaceutical group in the world and the third largest in Europe in terms of sales (IMS data 2015 Moving Annual Total September 2015). In the remainder of this section: · A product is referred to either by its international non-proprietary name (INN) or its brand name, which is generally exclusive to the company that markets it.  ... More ...  

Risk Grade

Where does SNY fit in the risk graph?

Risk Grade Scale

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?